Interleukin 17A Exacerbates Atherosclerosis by Promoting Fatty Acid-binding Protein 4-mediated ER Stress in Macrophages
Overview
Authors
Affiliations
Rationale: Apoptosis and fatty acid-binding protein-4 (FABP4) induced-endoplasmic reticulum (ER) stress in macrophage is an important pathological process in several vascular occlusive diseases, including atherosclerosis, both of which are accelerated by lipids or inflammatory cytokines.
Objective: To determine whether interleukin 17A (IL-17A) accelerates atherosclerosis through activating FABP4-mediated ER stress in macrophage.
Methods And Results: We show here that IL-17A induced ER stress in both murine and human-derived macrophages in vitro, and in the atherosclerotic lesions of ApoE-/- mice. Treating ApoE-/- mice with a chemical chaperone alleviated IL-17A-mediated ER stress and macrophage apoptosis, which was accompanied by recovered atherogenesis. Mechanistically, IL-17A up-regulated the expression of FABP4 (aP2), a cytosolic lipid chaperone that is able to promote lipid-induced macrophage ER stress, through NF-κB and ERK/p38 mitogen-activated protein kinase (MAPK) pathways in macrophages. The inhibition of aP2 expression with a specific chemical inhibitor significantly blocked IL-17A-accelerated ER stress and apoptosis in plaque, and partially rescued IL17A-induced atherogenesis.
Conclusions: The data collectively establish a previously unrecognized link between IL-17A and ER stress through cytosolic lipid chaperone aP2 in macrophages and provide a new insight for understanding the role of IL-17A in atherosclerosis.
Inhibition of FABP4 attenuates cardiac fibrosis through inhibition of NLRP3 inflammasome activation.
Zhu X, Zhang X, Cong X, Zhu L, Ning Z Iran J Basic Med Sci. 2022; 25(10):1260-1266.
PMID: 36311201 PMC: 9588312. DOI: 10.22038/IJBMS.2022.64499.14186.
Zhang W, Zhang Y, Zhu Q J Inflamm (Lond). 2022; 19(1):7.
PMID: 35706027 PMC: 9202166. DOI: 10.1186/s12950-022-00304-z.
Chang G, Yang X, Liu W, Lin S, Yang S, Zhao M Mol Ther Nucleic Acids. 2021; 24:743-754.
PMID: 33996256 PMC: 8094592. DOI: 10.1016/j.omtn.2021.03.020.
Shimada K, Porritt R, Markman J, ORourke J, Wakita D, Noval Rivas M Immunity. 2018; 49(5):873-885.e7.
PMID: 30366765 PMC: 6260980. DOI: 10.1016/j.immuni.2018.08.022.
Endoplasmic reticulum stress: a novel mechanism and therapeutic target for cardiovascular diseases.
Liu M, Chen Z, Chen L Acta Pharmacol Sin. 2016; 37(4):425-43.
PMID: 26838072 PMC: 4820795. DOI: 10.1038/aps.2015.145.